BSE Live
Apr 10, 10:02Prev. Close
157.75
Open Price
156.15
Bid Price (Qty.)
157.05 (40)
Offer Price (Qty.)
162.65 (35)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Makers Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | |
| Total Share Capital | 4.92 | 4.92 | 4.92 | 4.92 | 4.92 | |
| Reserves and Surplus | 39.70 | 36.78 | 31.90 | 29.15 | 21.42 | |
| Total Reserves and Surplus | 39.70 | 36.78 | 31.90 | 29.15 | 21.42 | |
| Total Shareholders Funds | 44.62 | 41.70 | 36.82 | 34.06 | 26.34 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 5.98 | 5.97 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 1.68 | 0.88 | 0.74 | 0.80 | 0.50 | |
| Other Long Term Liabilities | 2.05 | 0.00 | 0.00 | 0.00 | 3.72 | |
| Long Term Provisions | 0.19 | 0.17 | 0.19 | 0.23 | 0.18 | |
| Total Non-Current Liabilities | 9.90 | 7.02 | 0.93 | 1.03 | 4.39 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2.53 | 0.02 | 1.29 | 1.43 | 0.18 | |
| Trade Payables | 7.71 | 3.93 | 6.68 | 7.16 | 7.50 | |
| Other Current Liabilities | 7.43 | 6.14 | 6.62 | 5.49 | 0.57 | |
| Short Term Provisions | 1.69 | 1.20 | 0.95 | 1.03 | 1.22 | |
| Total Current Liabilities | 19.36 | 11.29 | 15.54 | 15.11 | 9.48 | |
| Total Capital And Liabilities | 73.88 | 60.01 | 53.29 | 50.20 | 40.21 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 32.82 | 18.10 | 16.61 | 17.29 | 10.35 | |
| Intangible Assets | 0.07 | 0.00 | 0.00 | 0.02 | 0.04 | |
| Capital Work-In-Progress | 0.69 | 6.42 | 0.11 | 0.15 | 4.23 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 33.57 | 24.52 | 16.72 | 17.45 | 14.62 | |
| Non-Current Investments | 15.04 | 11.16 | 8.18 | 7.12 | 2.35 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.32 | 0.35 | 0.22 | 0.04 | 0.31 | |
| Other Non-Current Assets | 1.17 | 1.19 | 0.53 | 0.59 | 0.32 | |
| Total Non-Current Assets | 50.11 | 37.23 | 25.65 | 25.20 | 17.59 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | |
| Inventories | 10.69 | 11.65 | 13.35 | 7.99 | 6.11 | |
| Trade Receivables | 7.55 | 5.02 | 11.22 | 12.06 | 14.41 | |
| Cash And Cash Equivalents | 0.96 | 2.25 | 0.23 | 4.19 | 1.21 | |
| Short Term Loans And Advances | 0.01 | 0.01 | 0.01 | 0.04 | 0.41 | |
| OtherCurrentAssets | 4.56 | 3.86 | 1.83 | 0.71 | 0.48 | |
| Total Current Assets | 23.77 | 22.79 | 27.64 | 25.00 | 22.62 | |
| Total Assets | 73.88 | 60.01 | 53.29 | 50.20 | 40.21 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 2.08 | 2.56 | 1.05 | 0.19 | 0.25 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | |
| Capital Goods | 0.95 | 1.12 | 0.00 | 0.00 | 0.17 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.03 | 0.01 | 0.25 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 14.29 | 10.42 | 7.35 | 6.33 | 5.88 | |
| Non-Current Investments Unquoted Book Value | 0.75 | 0.74 | 0.83 | 0.79 | 1.34 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | 1.00 | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth